I am...
- All
- HLH/FEL/FHL
- LCH
- Rare Histiocytic Disorders and Other Topics
- RDD
Proteolytic Maturation of Perforin: Determining the Requirements for Cytotoxic Function
Principal Investigator Kimberly Risma MD, PhD Cincinnati Children’s Hospital Medical Center – Cincinnati, Ohio USA Date of…
Mechanistic Studies of Defects in Lymphocyte Cytotoxicity Underlying HLH
Principal Investigator Yenan Bryceson, PhD Center for Infectious Medicine – Stockholm, Sweden Date of Award December 2010…
Hybrid ImmunoTherapy (ATG/Dexamethasone/Etoposide) for Hemophagocytic Lymphohistiocytosis: The HIT-HLH trial
Principal Investigator Michael Jordan, MD Cincinnati Children’s Hospital Medical Center – Cincinnati, Ohio USA Date of Award…
Gene-Expression Profiling of Peripheral Blood Mononuclear Cells in Memophagocytic Lymphohistiocytosis
Principal Investigator Janos Sumegi MD DSc PhD Cincinnati Children’s Hospital Medical Center – Cincinnati, Ohio USA Date…
The Role of BRAF V600E in the Pathogenesis of Langerhans Cell Histiocytosis
Principal Investigator Gayane Badalian Very Dana-Farber Cancer Institute – Boston, Massachusetts USA Date of Award December 2010…
Identifying Familial Associations in Langerhans Cell Histiocytosis Using the Utah Population Database
Principal Investigator Mark Fluchel, MD Primary Children’s Hospital – Salt Lake City, Utah USA Date of Award…
Histiocyte Society Clinical Trials Database System LCH-IV Treatment Protocol Study
Project Administrators Histiocyte Society Executive Board LCH Study Reference Center – Vienna, Austria Date of Award December…
Gene Expression Strategy to Identifiy the Cell of Origin in Langerhans Cell Histiocytosis
Principal Investigator Carl E. Allen Texas Children’s Hospital – Houston, Texas USA Date of Award December 2010…
Flow Cytometric and Secretomic Analysis of LCH Lesions
Principal Investigator Matthew Collin Institute of Cellular Medicine – Newcastle upon Tyne UK Date of Award December…